Skip to content
Evigrade
CriticalMacrolide antibiotic×First-generation antihistamine with anxiolytic activity

Updated · Methodology

Mechanism

Hydroxyzine is associated with QT prolongation. Post-marketing cases of QT prolongation and torsade de pointes occurred mostly in people with other risk factors, electrolyte disturbances or concomitant medicines (hydroxyzine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Erythromycin also prolongs cardiac repolarisation and the QT interval, which carries a risk of arrhythmia and torsade de pointes (erythromycin SmPC, AEMPS). The Spanish hydroxyzine SmPC names erythromycin among the drugs that raise the risk of arrhythmia when taken with hydroxyzine (AEMPS). Erythromycin also moderately inhibits CYP3A4, and alcohol dehydrogenase and CYP3A4/5 metabolise hydroxyzine (erythromycin and hydroxyzine SmPCs, AEMPS). The hydroxyzine SmPCs expect higher hydroxyzine levels with strong inhibitors of these enzymes, and erythromycin is not among their examples of strong inhibitors. When an inhibitor blocks only one pathway, the other can partly compensate (hydroxyzine SmPCs, AEMPS).

Symptoms

QT prolongation itself causes no symptoms and shows only on an electrocardiogram (ECG). The adverse reactions of hydroxyzine include QT prolongation, ventricular arrhythmias such as torsade de pointes, and loss of consciousness (hydroxyzine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The erythromycin SmPC lists QT prolongation, ventricular tachyarrhythmia, palpitations, torsade de pointes, ventricular fibrillation and cardiac arrest. Deaths have also been reported with macrolide-related QT prolongation (erythromycin SmPC, AEMPS). Older people may be more sensitive to the effect of erythromycin on the QT interval (erythromycin label, US Food and Drug Administration, FDA).

Management

The combination is contraindicated. The Spanish hydroxyzine summary of product characteristics (SmPC) contraindicates hydroxyzine with drugs that prolong the QT interval or cause torsade de pointes and names erythromycin (hydroxyzine SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The Spanish erythromycin SmPC and the US hydroxyzine label only advise caution with this combination (erythromycin SmPC, AEMPS; hydroxyzine label, US Food and Drug Administration, FDA); the Spanish hydroxyzine SmPC is stricter. Hydroxyzine is also contraindicated in known QT prolongation, cardiovascular disease, low potassium or magnesium, a family history of sudden cardiac death and significant bradycardia (hydroxyzine SmPC, AEMPS). Do not prescribe erythromycin to people with a history of QT prolongation or ventricular arrhythmia, or with low potassium or magnesium (erythromycin SmPC, AEMPS). No document sets an interval between stopping one drug and starting the other. The half-life of erythromycin is about 2 hours, and that of hydroxyzine is about 14 hours, up to 29 hours in older people (erythromycin and hydroxyzine SmPCs, AEMPS). If hydroxyzine and erythromycin have nevertheless been taken together and signs of arrhythmia appear, stop hydroxyzine (hydroxyzine SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Erythromycin

Other interactions with Hydroxyzine